Targeting MMPs inhibits ovarian cancer metastasis. Dendrosomal nanocurcumin maximizes cell death and synergizes with oxaliplatin to inhibit growth. Differential expression of MMP‐2 and MMP‐9 was observed. Here, MMP2 is linked to ovarian carcinoma.